Larcaviximab
Based on 1 Customer Validation
Larcaviximab (c4G7-N) is an IgG1 kappa chimeric monoclonal antibody against Ebola virus glycoprotein, which is applicable to studies related to Ebola virus infection.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 96.13%
- CAS. Nr.: 1792982-56-9
- Molecular Weight:144.96 kDa
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Human IgG1 kappa
Virus
Zaire Ebola virus
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
911829 [NCBI]
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Human IgG1 kappa
ELISA, FACS, Functional assay
Chemical Information
-
CAS. Nr. 1792982-56-9
-
Appearance Liquid
-
Molecular Weight 144.96 kDa
-
Color Colorless to light yellow
-
SMILES
[Larcaviximab]
-
Synonyms
c4G7-N
-
Versand
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
-
Data Sheet (256 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)